NASDAQ · MGPI

MGP Ingredients Inc.

$17.96 +$0.27 (+1.53%) 1D After hours

Key Metrics

$378.06M
Market cap
P/E · TTM
$521.15M
Revenue · TTM
−$239.59M
Net income
EPS · TTM $-11.23
Dividend yield 2.7%
Free cash flow $52.52M
Beta · 1Y 0.31
EBITDA · TTM −$248.09M
Gross margin 36.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 17
    From its Feb 4 high, the share price fell 40%.

    Peak close $26.40 on Feb 4; trough close $15.76 on Jun 17. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -40%
  • Feb 25
    The stock moved -21.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$378.06M
Enterprise value$612.66M
Shares outstanding21.4M
52-wk range$15.72 – $31.75
Avg volume · 20D195.1K
Net cash −$234.60M
Book value / share$27.24
IndustryWholesale-Beer, Wine & Distilled Alcoholic Beverages
ExchangeNASDAQ
About MGP Ingredients Inc.
IPO dateOct 20, 1988
Employees617

MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.73
P/FCF7.20
EV/EBITDA
EV/Sales1.18
Graham №

Profitability

Gross 36.4%
Operating -52.3%
Net -46.0%
FCF 10.1%
ROE / ROIC -33.9% · -29.4%

Financial Health

Current ratio2.74
Quick ratio
Debt / equity0.42
Debt / EBITDA -0.99
Net cash −$234.60M
Working capital$321.06M

Cash Flow · TTM

Operating CF $83.80M
Capex −$31.28M
Free cash flow $52.52M
Buybacks $886.00K
Dividends paid $10.35M
Shareholder yield 3.0%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

0.9
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings